STOCK TITAN

LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

LogicBio Therapeutics (Nasdaq: LOGC) announced its participation in the Jefferies Virtual Healthcare Conference on June 2, 2020, at 8:00 a.m. ET. The event will feature a live audio webcast available on the company's website, with a replay accessible shortly after the presentation for 30 days.

LogicBio focuses on genome editing to develop medicines for rare pediatric diseases using its GeneRide technology, which enables precise integration of therapeutic transgenes for potentially lifelong expression. More information can be found at www.logicbio.com.

Positive
  • None.
Negative
  • None.

LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced it will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 8:00 a.m. ET.

A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.

About LogicBio Therapeutics
LogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology platform. GeneRide enables the site-specific integration of a therapeutic transgene in a nuclease-free and promoterless approach by relying on the native process of homologous recombination to drive potential lifelong expression. Headquartered in Lexington, Mass., LogicBio is committed to developing medicines that will transform the lives of pediatric patients and their families.

For more information, please visit www.logicbio.com.

Contacts:

Brian Luque
Associate Director, Investor Relations
bluque@logicbio.com
951-206-1200


FAQ

When is LogicBio Therapeutics presenting at the Jefferies Virtual Healthcare Conference?

LogicBio Therapeutics will present at the Jefferies Virtual Healthcare Conference on June 2, 2020, at 8:00 a.m. ET.

How can I access the presentation from LogicBio Therapeutics?

The presentation will be available via a live audio webcast on LogicBio's website and can be replayed for 30 days after the event.

What is the focus of LogicBio Therapeutics?

LogicBio Therapeutics specializes in genome editing to develop treatments for rare pediatric diseases.

What technology does LogicBio use for its treatments?

LogicBio employs its proprietary GeneRide technology, which allows for targeted integration of therapeutic transgenes.

Where is LogicBio Therapeutics headquartered?

LogicBio Therapeutics is headquartered in Lexington, Massachusetts.

Contextlogic Inc.

NASDAQ:LOGC

LOGC Rankings

LOGC Latest News

LOGC Stock Data

226.31M
24.67M
3.72%
51.18%
10.32%
Internet Retail
Retail-catalog & Mail-order Houses
Link
United States
OAKLAND